Compound as MYT1 inhibitor
JP2025523030A5Pending Publication Date: 2026-07-21WIGEN BIOMEDICINE TECH (SHANGHAI) CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- WIGEN BIOMEDICINE TECH (SHANGHAI) CO LTD
- Filing Date
- 2023-07-10
- Publication Date
- 2026-07-21
Smart Images
Figure 00000000_0000_ABST
Abstract
Compounds as MYT1 inhibitors are disclosed in the present invention. In particular, the present invention relates to compounds represented by general formula (1), methods for preparing the same, and the use of the compounds of general formula (1), and their isomers, their crystals, their pharmaceutically acceptable salts, their hydrates or their solvates as MYT1 inhibitors. The compounds of the present invention, and their isomers, their crystals, their pharmaceutically acceptable salts, their hydrates or their solvates can be used for preparing medicaments for treating or preventing diseases related to the MYT1 protein. TIFF2025523030000232.tif40168
Need to check novelty before this filing date? Find Prior Art